News
The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's ...
The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's ...
All-natural treatments like aromatherapy and mud facials used to be all the rage. But now, top hotels around the world are ...
This was the stock's second consecutive day of gains.
After more than 10 trips over the past two decades, stepping from the plane into Fiji's thick tropical humidity always feels ...
To secure the antibody, I-Mab is paying $1.8 million upfront to buy Bridge Health, to be followed by noncontingent quarterly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results